Stockreport

Serina Therapeutics to Present Novel Data on POZ-Lipid Technology Potentially Enhancing Safety and Efficacy of mRNA LNP Formulations at the 4th mRNA-Based Therapeutics Summit [Yahoo! Finan...

Serina Therapeutics, Inc.  (SER) 
PDF its proprietary POZ Platform TM drug delivery technology, today announced that Randall Moreadith, MD, Ph.D., Chief Development Officer, will present at the 4th Annual mR [Read more]